陈正军组关于上皮细胞极性建立机制的研究取得突破

2006年11月1日出版的EMBOJ发表了上海生科院生化与细胞所陈正军课题组关于EGFR信号通路调控上皮细胞极性建立的最新研究成果,该工作首次确定了生长因子受体与Src家族成员协同介导重要极性蛋白Par3磷酸化直接调控上皮细胞极性建立的分子机理,从而首次揭示了一种新的酪氨酸磷酸化依赖性的上皮细胞极性形成的调控机制。细胞极性对多细胞有机体的发育是至关重要的,而上皮细胞极性的建立与维持对于各器官正常功能的运转是必不可少的。由Par3、Par6和aPKC组成的保守复合物是各种细胞极性建立以及细胞不对称分裂的核心部件。尽管对该复合物…     

Angiomotin在肿瘤形成及Hippo信号通路中调控研究进展

Angiomotin(AMOT)是一种血管抑制素结合蛋白,AMOT在血管内皮细胞的迁移、紧密连接和管状形成等方面起着重要调控作用。AMOT及其同源家族蛋白AMOTL1和AMOTL2可能与Hippo信号通路的下游效应分子YAP相互作用来参与调控肿瘤细胞的生长。在乳腺癌、前列腺癌等癌症中,AMOT能够增加YAP进入细胞核的水平从而促进癌细胞的增殖和迁移;但在胶质母细胞瘤、肺癌等癌细胞中,AMOT将YAP滞留在细胞质或紧密连接处,从而抑制YAP的活性。另外,AMOT也可以促进Hippo信号通路中核心激酶LATS来发挥抑制肿瘤细胞增殖的作用。AMOT在肿瘤细胞生长中发挥的不同作用还需要更深入的研究,现对AMOT在癌症中的调控作用及在Hippo信号通路中的调控机制等方面的研究进展进行综述。     

雌激素受体信号通路在乳腺癌发生和治疗中的作用

雌激素受体信号通路在调控乳腺细胞增殖和凋亡等生理机能中发挥重要功能,该通路出现调控异常时可导致乳腺癌发生。雌激素受体在乳腺癌发生中的作用机制包括核受体介导的基因组信号通路和膜受体介导的非基因组信号通路以及二者的相互作用。基于雌激素受体信号通路及其关键信号分子的靶向治疗是开展乳腺癌治疗的重要策略与有效途径。对雌激素受体结构以及雌激素受体信号通路在乳腺癌发生和治疗中的作用作一综述。     

柯萨奇病毒B组5型非结构蛋白抑制NF-κB信号通路的作用机制研究

目的 柯萨奇病毒B组5型（CVB5）是手足口病的重要病原体之一,可导致发热、皮疹或疱疹等临床症状,重症者出现神经系统疾病,甚至死亡。天然免疫应答是机体抗病毒入侵的第一道防线,其中核因子κB (NF-κB)是宿主天然免疫反应中的重要蛋白质,然而关于CVB5感染后调控NF-κB介导信号通路的研究尚鲜有报道。方法 本研究通过检测启动子活性、促炎因子水平以及通路中关键蛋白表达等,阐明CVB5对NF-κB信号通路的调控作用机制。结果 CVB5感染可抑制促炎因子表达和p65的磷酸化。CVB5非结构蛋白（NSP）可抑制促炎因子表达以及重要蛋白p65和IκBα的磷酸化。经STRING11.1数据库预测表明,CVB5 3CD蛋白与宿主多聚胞嘧啶结合蛋白1 (PCBP1)具有相互作用,且PCBP1可促进IκBα和p65的磷酸化,抑制病毒复制。结论 CVB5 NSP可负调控NF-κB信号通路,且与3CD相互作用的PCBP1蛋白可通过调控NF-κB通路抑制CVB5复制。本研究探索病毒与宿主天然免疫应答的调控作用,从而为研制抗CVB5感染的药物提供作用靶点。     

Hippo信号通路结构生物学研究进展

生物体内存在多种信号转导通路参与发育调控和组织稳态维持等重要过程,其信号异常与多种疾病特别是癌症的发生和发展密切相关。进化上高度保守的Hippo信号通路在个体发育和稳态平衡中发挥极为关键的作用。Hippo信号通路主要通过一系列相关激酶的相互作用和级联磷酸化来传递信号,能抑制细胞增殖并促进凋亡,在很多组织器官中控制细胞数量和器官大小。Hippo信号通路在一系列恶性肿瘤中出现显著异常,被认为是癌症治疗和再生医学的重要靶标。目前,Hippo信号通路中大部分关键组分已经确定,而其具体信号调控机制及功能正在完善之中。本文总结了目前已知的Hippo信号通路各蛋白成员的结构信息,重点从结构生物学角度对其信号的转导与调控机制进行分析,并对已有的Hippo信号通路靶向小分子及多肽抑制剂进行梳理,以期深化人们对该通路关键蛋白质机器的理解,并进一步促进相关的功能研究和潜在的治疗干预研发。     

糖原合酶激酶-3β在肿瘤细胞中的分子作用机制

糖原合酶激酶-3β(glycogen synthase kinase-3β,GSK-3β)是一种多功能丝氨酸/苏氨酸激酶,通过磷酸化酪氨酸、丝氨酸和苏氨酸位点介导Wnt、Hedgehog、NF-κB和PI3K/Akt等信号通路,参与各类细胞功能的调节。GSK-3β在不同信号通路和细胞类型中扮演不同的角色,导致其在不同的恶性肿瘤中发挥促癌或抑癌的双重作用,与癌细胞的迁移和侵袭有直接关系。在胰腺癌和结肠癌研究中,GSK-3β的高表达调控通过相关信号通路,增强细胞增殖调控因子表达,抑制负性调控因子的活性,促进癌细胞的增殖。GSK-3β能激活上皮细胞间质转型过程中相关因子的表达,增强癌细胞扩散能力;相反,在胃癌和肺癌中,GSK-3β具有积极的抑癌作用。GSK-3β通过阻滞细胞周期和诱导细胞凋亡发挥抑癌作用,通过调节Wnt和PI3K/Akt信号通路,负向调控癌细胞的生长与侵袭,并且GSK-3β磷酸化相关因子以减弱其对癌细胞转移能力的刺激。本文总结了GSK-3β在不同恶性肿瘤中的作用及机制,并针对研究中存在的问题进行分析与展望,为相关领域的研究提供一定的理论基础。     

表皮形态发生素(Epimorphin)与表皮形态发生

表皮形态发生素（epimorphin 又称为syntaxin2）是哺乳动物中高度保守的一个间质细胞表面膜蛋白,胞外区包含有1个19个氨基酸残基的部位（NL肽序列）,是其与细胞的结合位点,但发挥效应必须有其它的胞外区存在.目前,已经发现它调控下游的2个分子MMP3和C/EBPβ,但对于其信号通路还知之甚少,推测其可能通过直接或者间接磷酸化表皮生长因子受体（EGFR）而激发MAPK/ERK信号通路.它在多种表皮组织（包括肺、肠、肝、乳腺、胰腺、毛囊、胆囊、血管内皮等）的表皮形态发生,尤其是腺管状结构的形态发生过程中发挥重要作用.依靠极性和非极性2种不同的表达方式,epimorphin可以选择性介导腺管形态发生的2个关键过程:分支形态发生和腔形态发生,分支状形态发生涉及到腺管的发生和延展,腔形态发生涉及到腺管直径的增大.     

顶- 底极性复合物与癌症的关系研究进展

顶-底极性是上皮细胞的一项主要特征,参与细胞形态、迁移、功能维持等多个生物学事件。上皮细胞顶-底极性复合物包括PAR复合物、SCRIB复合物和CRB复合物。丧失极性是细胞癌化的标志之一,并且在人类癌症中也发现了顶-底极性复合物的异常表达。本文将就目前有关顶-底极性复合物在癌症方面的研究进行综述,重点阐述顶-底极性复合物在肿瘤发生、发展过程中的作用及调控机制。     

肝细胞生长因子及受体传递的调节与内吞作用

肝细胞生长因子(HGF)是一种具有多重功能的细胞调控因子。HGF与其受体Met酪氨酸激酶(c-Met)的结合可激发多种生物学反应,从而调节细胞的增殖、分化、形态发生和侵袭运动等。有多种因素参与了HGF/c-Met信号传导的调控,从而防止信号的过度放大,其中Cbl1、Rab、泛素化激酶和HGF/c-Met的内吞等发挥了重要的作用。因此,对HGF/c-Met内吞过程的研究,了解内吞对于HGF/c-Met的信号传导及其调控的影响,探讨HGF/c-Met信号传导通路的调控机理和相互作用模式,可进一步阐明HGF/c-Met信号传导的调控机制,从而验证肝细胞中内吞作用直接调节HGF/c-Met信号通路的作用机制。     

Kremen2生物学功能研究进展

Kremen2 (kringle-containing transmembrane protein 2)是经典Wnt信号通路中的重要调控因子。起初Kremen2蛋白仅被认为是Wnt信号通路的抑制因子,但后期研究发现Kremen2蛋白在某些特定的生物环境中却发挥促进Wnt信号通路活化的作用。在对Wnt信号通路的调控过程中, Kremen2蛋白需要与多种蛋白质调控因子相互作用,以参与胚胎发育、骨形成、肿瘤发生等多种生理病理过程。通过对Kremen2相关研究文献的整理,本文综述了Kremen2蛋白的发现与分子结构,以及其主要的相互作用因子和蛋白质功能,并提出了相关研究展望。     

KIBRA suppresses apical exocytosis through inhibition of aPKC kinase activity in epithelial cells

Epithelial cells possess apical-basolateral polarity and form tight junctions (TJs) at the apical-lateral border, separating apical and basolateral membrane domains. The PAR3-aPKC-PAR6 complex plays a central role in TJ formation and apical domain development during tissue morphogenesis. Inactivation and overactivation of aPKC kinase activity disrupts membrane polarity. The mechanism that suppresses active aPKC is unknown. KIBRA, an upstream regulator of the Hippo pathway, regulates tissue size in Drosophila and can bind to aPKC. However, the relationship between KIBRA and the PAR3-aPKC-PAR6 complex remains unknown. We report that KIBRA binds to the PAR3-aPKC-PAR6 complex and localizes at TJs and apical domains in epithelial tissues and cells. The knockdown of KIBRA causes expansion of the apical domain in MDCK three-dimensional cysts and suppresses the formation of apical-containing vacuoles through enhanced de novo apical exocytosis. These phenotypes are restored by inhibition of aPKC. In addition, KIBRA directly inhibits the kinase activity of aPKC in vitro. These results strongly support the notion that KIBRA regulates epithelial cell polarity by suppressing apical exocytosis through direct inhibition of aPKC kinase activity in the PAR3-aPKC-PAR6 complex.     

The signaling adaptor gab1 regulates cell polarity by acting as a par protein scaffold

Cell polarity plays a key role in development and is disrupted in tumors, yet the molecules and mechanisms that regulate polarity remain poorly defined. We found that the scaffolding adaptor GAB1 interacts with two polarity proteins, PAR1 and PAR3. GAB1 binds PAR1 and enhances its kinase activity. GAB1 brings PAR1 and PAR3 into a transient complex, stimulating PAR3 phosphorylation by PAR1. GAB1 and PAR6 bind the PAR3 PDZ1 domain and thereby compete for PAR3 binding. Consequently, GAB1 depletion causes PAR3 hypophosphorylation and increases PAR3/PAR6 complex formation, resulting in accelerated and enhanced tight junction formation, increased transepithelial resistance, and lateral domain shortening. Conversely, GAB1 overexpression, in a PAR1/PAR3-dependent manner, disrupts epithelial apical-basal polarity, promotes multilumen cyst formation, and enhances growth factor-induced epithelial cell scattering. Our results identify GAB1 as a negative regulator of epithelial?cell polarity that functions as a scaffold for modulating PAR protein complexes on the lateral membrane.     

Diversity of tight junctions (TJs) between gastrointestinal epithelial cells and their function in maintaining the mucosal barrier

The gastrointestinal epithelium, which is covered by a single layer of epithelial cells, including enterocytes, intraepithelial lymphocytes, goblet cells, microfold cells, and dendritic cells, serves as a protective barrier separating luminal contents from the underlying tissue compartments. The epithelium plays an important role in the first line of host defense against a variety of pathogens, as well as maintaining the homeostasis in gastrointestinal tract. All these epithelial cells express junction complex proteins and form cell junctions such as adherens and TJs, although the TJs have small differences among different epithelial cells. The TJs, located most apically on the lateral membrane, are required for the proper formation of epithelial cell polarity as well as sustaining of the mucosal barrier. Furthermore, TJs are the key cell junctions modulating the paracellular pathway. Understanding the diversity of the TJs between intestinal epithelial cells and their different roles in defending pathogens' invasion and modifying the paracellular pathway are attractive to exploration.     

aPKC acts upstream of PAR-1b in both the establishment and maintenance of mammalian epithelial polarity

BACKGROUND: aPKC and PAR-1 are required for cell polarity in various contexts. In mammalian epithelial cells, aPKC localizes at tight junctions (TJs) and plays an indispensable role in the development of asymmetric intercellular junctions essential for the establishment and maintenance of apicobasal polarity. On the other hand, one of the mammalian PAR-1 kinases, PAR-1b/EMK1/MARK2, localizes to the lateral membrane in a complimentary manner with aPKC, but little is known about its role in apicobasal polarity of epithelial cells as well as its functional relationship with aPKC. RESULTS: We demonstrate that PAR-1b is essential for the asymmetric development of membrane domains of polarized MDCK cells. Nonetheless, it is not required for the junctional localization of aPKC nor the formation of TJs, suggesting that PAR-1b works downstream of aPKC during epithelial cell polarization. On the other hand, aPKC phosphorylates threonine 595 of PAR-1b and enhances its binding with 14-3-3/PAR-5. In polarized MDCK cells, T595 phosphorylation and 14-3-3 binding are observed only in the soluble form of PAR-1b, and okadaic acid treatment induces T595-dependent dissociation of PAR-1b from the lateral membrane. Furthermore, T595A mutation induces not only PAR-1b leakage into the apical membrane, but also abnormal development of membrane domains. These results suggest that in polarized epithelial cells, aPKC phosphorylates PAR-1b at TJs, and in cooperation with 14-3-3, promotes the dissociation of PAR-1b from the lateral membrane to regulate PAR-1b activity for the membrane domain development. CONCLUSIONS: These results suggest that mammalian aPKC functions upstream of PAR-1b in both the establishment and maintenance of epithelial cell polarity.     

The role of epithelial tight junctions involved in pathogen infections

Tight junctions (TJs) are sealing complexes between adjacent epithelial cells, functioning by controlling paracellular passage and maintaining cell polarity. These functions of TJs are primarily based on structural integrity as well as dynamic regulatory balance, indicating plasticity of TJ in response to external stimuli. An indispensable role of TJs involved in pathogen infection has been widely demonstrated since disruption of TJs leads to a distinct increase in paracellular permeability and polarity defects which facilitate viral or bacterial entry and spread. In addition to pathological changes in TJ integrity, TJ proteins such as occludin and claudins can either function as receptors for pathogen entry or interact with viral/bacterial effector molecules as an essential step for characterizing an infective stage. This suggests a more complicated role for TJ itself and especially specific TJ components. Thus, this review surveys the role of the epithelial TJs involved in various pathogen infections, and extends TJ targeted therapeutic and pharmacological application prospects.     

Lipid polarity is maintained in absence of tight junctions

The role of tight junctions (TJs) in the establishment and maintenance of lipid polarity in epithelial cells has long been a subject of controversy. We have addressed this issue using lysenin, a toxin derived from earthworms, and an influenza virus labeled with a fluorescent lipid, octadecylrhodamine B (R18). When epithelial cells are stained with lysenin, lysenin selectively binds to their apical membranes. Using an artificial liposome, we demonstrated that lysenin recognizes the membrane domains where sphingomyelins are clustered. Interestingly, lysenin selectively stained the apical membranes of epithelial cells depleted of zonula occludens proteins (ZO-deficient cells), which completely lack TJs. Furthermore, the fluorescent lipid inserted into the apical membrane by fusion with the influenza virus did not diffuse to the lateral membrane in ZO-deficient epithelial cells. This study revealed that sphingomyelin-cluster formation occurs only in the apical membrane and that lipid polarity is maintained even in the absence of TJs.     

Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells

Claudins are integral membrane proteins essential in the formation and function of tight junctions (TJs). Disruption of TJs, which have essential roles in cell permeability and polarity, is thought to contribute to epithelial tumorigenesis. Claudin-3 and -4 are frequently overexpressed in ovarian cancer, but the molecular pathways involved in the regulation of these proteins are unclear. Interestingly, several studies have demonstrated a role for phosphorylation in the regulation of TJ complexes, although evidence for claudin phosphorylation is scarce. Here, we showed that claudin-3 and -4 can be phosphorylated in ovarian cancer cells. In vitro phosphorylation assays using glutathione S-transferase fusion constructs demonstrated that the C terminus of claudin-3 is an excellent substrate for cAMP-dependent protein kinase (PKA). Using site-directed mutagenesis, we identified a PKA phosphorylation site at amino acid 192 in the C terminus of claudin-3. Overexpression of the protein containing a T192D mutation, mimicking the phosphorylated state, resulted in a decrease in TJ strength in ovarian cancer cell line OVCA433. Our results suggest that claudin-3 phosphorylation by PKA, a kinase frequently activated in ovarian cancer, may provide a mechanism for the disruption of TJs in this cancer. In addition, our findings may have general implications for the regulation of TJs in normal epithelial cells.     

Direct binding of cell polarity protein PAR-3 to cell-cell adhesion molecule nectin at neuroepithelial cells of developing mouse

PAR-3 is a cell polarity protein that localizes at tight junctions (TJs) by direct binding to an immunoglobulin (Ig)-like cell-cell adhesion molecule JAM-1 in mammalian epithelial cells. Another Ig-like cell-cell adhesion molecule nectin plays a role in the localization of JAM-1 at TJs in epithelial cells. Nectin furthermore plays a role in the organization of adherens junctions (AJs) and TJs. Nectin comprises a family of four members, nectin-1, -2, -3, and -4. Nectins are associated with the actin cytoskeleton through afadin, of which the PDZ domain binds to nectins through their C-terminal four amino acids. We show here that PAR-3 binds to nectin-1 and -3 in neuroepithelial cells of the embryonic telencephalon, which are equipped with AJs, but not with typical TJs. Nectin-1, -2, -3, and afadin, but not JAM-1, were concentrated at AJs in neuroepithelial cells of the embryonic telencephalon at E13.5 and PAR-3 co-localized with nectins. PAR-3 was co-immunoprecipitated with nectin-1 and -3, but not with nectin-2 or JAM-1, from the mouse whole brain at E13.5. Recombinant PAR-3 stoichiometrically bound to recombinant nectin-1 and -3. The first one of the three PDZ domains of PAR-3 bound to the C-terminal four amino acids of nectin-1 and -3. The affinities of PAR-3 and afadin for nectin-1 and -3 were similar. Cadherin-deficient L cells expressing nectin-1 and -3 formed nectin-1- and -3-based cell-cell junctions, respectively, where PAR-3 as well as afadin was recruited. These results indicate that nectin-1 and -3 are involved in the localization of PAR-3 at AJs in the neuroepithelial cells of the embryonic telencephalon.     

A distinct PAR complex associates physically with VE-cadherin in vertebrate endothelial cells

A cell polarity complex consisting of partitioning defective 3 (PAR-3), atypical protein kinase C (aPKC) and PAR-6 has a central role in the development of cell polarity in epithelial cells. In vertebrate epithelial cells, this complex localizes to tight junctions. Here, we provide evidence for the existence of a distinct PAR protein complex in endothelial cells. Both PAR-3 and PAR-6 associate directly with the adherens junction protein vascular endothelial cadherin (VE-cadherin). This association is direct and mediated through non-overlapping domains in VE-cadherin. PAR-3 and PAR-6 are recruited independently to cell-cell contacts. Surprisingly, the VE-cadherin-associated PAR protein complex lacks aPKC. Ectopic expression of VE-cadherin in epithelial cells affects tight junction formation. Our findings suggest that in endothelial cells, another PAR protein complex exists that localizes to adherens junctions and does not promote cellular polarization through aPKC activity. They also point to a direct role of a cadherin in the regulation of cell polarity in vertebrates.     

Assembly of epithelial tight junctions is negatively regulated by Par6

Epithelial cells display apical-basal polarity, and the apical surface is segregated from the basolateral membranes by a barrier called the tight junction (TJ). TJs are constructed from transmembrane proteins that form cell-cell contacts-claudins, occludin, and junctional adhesion molecule (JAM)-plus peripheral proteins such as ZO-1. The Par proteins (partitioning-defective) Par3 and Par6, plus atypical protein kinase C (aPKC) function in the formation or maintenance of TJs and more generally in metazoan cell polarity establishment. Par6 contains a PDZ domain and a partial CRIB (Cdc42/Rac interactive binding) domain and binds the small GTPase Cdc42. Here, we show that Par6 inhibits TJ assembly in MDCK II epithelial cells after their disruption by Ca(2+) depletion but does not inhibit adherens junction (AJ) formation. Transepithelial resistance and paracellular diffusion assays confirmed that assembly of functional TJs is delayed by Par6 overexpression. Strikingly, the isolated, N-terminal fragment of PKCzeta, which binds Par6, also inhibits TJ assembly. Activated Cdc42 can disrupt TJs, but neither a dominant-negative Cdc42 mutant nor the CRIB domain of gammaPAK (p21-activated kinase), which inhibits Cdc42 function, observably inhibit TJ formation. These results suggest that Cdc42 and Par6 negatively regulate TJ assembly in mammalian epithelial cells.